Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
06 2019
Historique:
received: 10 08 2018
revised: 10 09 2018
accepted: 05 12 2018
pubmed: 26 12 2018
medline: 9 9 2020
entrez: 25 12 2018
Statut: ppublish

Résumé

Labeling locoregional failures in head and neck cancer (HNC) as "local" and "regional" becomes incomplete when treating with intensity modulated radiotherapy (IMRT). Target delineation and delivery errors, dose in-homogeneity complicate the assessment of failures. A combination of focal point and dosimetric method might attempt at simplifying failure analysis. One hundred eleven patients with locally advanced HNC treated with chemoradiation using IMRT were enrolled. Patients with documented failure had their recurrence volume assessed using focal point and dosimetric method. With a median follow-up of 20 (range 0-39) months and median locoregional control (LRC) of 30 (range 24.8-34.5) months, the patients had a 3-year overall survival and LRC of 70.6% and 48.9%, respectively. Of 39 failures, there were 69.2%, 7.6%, 5.1%, 12.8%, and 5.1% type A, B, C, D, and E, respectively using the focal point and dosimetric method. With the current classification, majority of the recurrences were high dose failures suggesting inherent radioresistance. While minority of failures were potentially preventable and needed modifying existing IMRT workflow.

Sections du résumé

BACKGROUND
Labeling locoregional failures in head and neck cancer (HNC) as "local" and "regional" becomes incomplete when treating with intensity modulated radiotherapy (IMRT). Target delineation and delivery errors, dose in-homogeneity complicate the assessment of failures. A combination of focal point and dosimetric method might attempt at simplifying failure analysis.
METHODS
One hundred eleven patients with locally advanced HNC treated with chemoradiation using IMRT were enrolled. Patients with documented failure had their recurrence volume assessed using focal point and dosimetric method.
RESULTS
With a median follow-up of 20 (range 0-39) months and median locoregional control (LRC) of 30 (range 24.8-34.5) months, the patients had a 3-year overall survival and LRC of 70.6% and 48.9%, respectively. Of 39 failures, there were 69.2%, 7.6%, 5.1%, 12.8%, and 5.1% type A, B, C, D, and E, respectively using the focal point and dosimetric method.
CONCLUSION
With the current classification, majority of the recurrences were high dose failures suggesting inherent radioresistance. While minority of failures were potentially preventable and needed modifying existing IMRT workflow.

Identifiants

pubmed: 30582238
doi: 10.1002/hed.25586
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1632-1637

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Sarthak Tandon (S)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Munish Gairola (M)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Parveen Ahlawat (P)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Ahmad Masroor Karimi (AM)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Sandeep Tiwari (S)

Department of Radiation Oncology, Manipal Hospitals Dwarka, New Delhi, India.

Vinayakumar Muttagi (V)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Nishtha Sachdeva (N)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Muhammed Ismail Sharief (MI)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Kiran Dobriyal (K)

Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH